Literature DB >> 33094868

Perfectionism, anorexia nervosa, and family treatment: How perfectionism changes throughout treatment and predicts outcomes.

Hannah A Welch1, W Stewart Agras1, James Lock1, Katherine A Halmi2.   

Abstract

OBJECTIVE: This study uses data from a multisite randomized clinical trial to study the role of perfectionism in family-based treatment (FBT) for adolescent anorexia nervosa (AN). The main aim is to examine the role of baseline perfectionism in treatment response.
METHOD: Adolescents (N = 158; ages 12-18; 89.2% female) and their families were randomized to receive either FBT or systemic family treatment for AN. Eating disorder (ED) pathology, obsessive-compulsive symptoms, and perfectionism were assessed at baseline, end of treatment, and 6- and 12-month follow-up. Linear regression analyses were used to test whether perfectionism and obsessive-compulsive symptoms at baseline predict ED pathology at all timepoints. An independent samples t test was used to test whether there was a significant difference in the change in perfectionism in either treatment group.
RESULTS: Baseline maladaptive perfectionism significantly predicted ED pathology but not ideal body weight at all timepoints. The model that included obsessive-compulsive symptoms also predicted ED pathology at all timepoints except 12-month follow-up. Perfectionism scores did not change during treatment regardless of treatment type. DISCUSSION: Baseline perfectionism predicted treatment response in this study. Interventions might target perfectionism to improve treatment response in AN.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  anorexia nervosa; family treatment; perfectionism

Mesh:

Year:  2020        PMID: 33094868     DOI: 10.1002/eat.23396

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  1 in total

1.  Can Cognitive Flexibility and Clinical Perfectionism Be Used to Identify People with Anorexia Nervosa?

Authors:  Stephanie Miles; Maja Nedeljkovic; Andrea Phillipou
Journal:  J Clin Med       Date:  2022-03-31       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.